Conference Coverage

EADV: Investigational biologic rocks psoriasis world


 

AT THE EADV CONGRESS

References

Pages

Recommended Reading

FUTURE 1 trial results fortify evidence base for secukinumab’s efficacy in psoriatic arthritis
Psoriatic Arthritis ICYMI
Brodalumab psoriasis results published, development plans continue
Psoriatic Arthritis ICYMI
PsA confers higher risk of cardiovascular disease, events
Psoriatic Arthritis ICYMI
Psoriasis severity correlates with aortic vascular inflammation
Psoriatic Arthritis ICYMI
Combined dermatology-rheumatology clinics improve care, spark new research
Psoriatic Arthritis ICYMI
EADV: Long-term weight loss curbs psoriasis severity
Psoriatic Arthritis ICYMI
EADV: Latest gruesome twosome: Psoriasis spawns renal disease
Psoriatic Arthritis ICYMI
Dactylitis warns of future damage in psoriatic arthritis
Psoriatic Arthritis ICYMI
Topical calcipotriene-betamethasone combination approved for plaque psoriasis
Psoriatic Arthritis ICYMI
Infections from endemic fungi, mycobacteria rare in patients on TNFIs
Psoriatic Arthritis ICYMI

Related Articles